Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis

J Clin Invest. 2002 Jan;109(2):285-6. doi: 10.1172/JCI14891.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Apoptosis*
  • Caspase 3
  • Caspases / metabolism
  • Chromosomal Proteins, Non-Histone / genetics*
  • Cisplatin / pharmacology
  • Cysteine Proteinase Inhibitors*
  • Gene Expression*
  • Humans
  • Inhibitor of Apoptosis Proteins
  • Melanoma
  • Microtubule-Associated Proteins*
  • Neoplasm Proteins
  • RNA, Catalytic / genetics
  • RNA, Catalytic / metabolism*
  • Survivin
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • BIRC5 protein, human
  • Chromosomal Proteins, Non-Histone
  • Cysteine Proteinase Inhibitors
  • Inhibitor of Apoptosis Proteins
  • Microtubule-Associated Proteins
  • Neoplasm Proteins
  • RNA, Catalytic
  • Survivin
  • hammerhead ribozyme
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • Cisplatin